Get started
Author

Lionel Duck

Observed names: Duck, Lionel, L Duck, L. Duck, L. R. Duck, Lionel DUCK, Vincent Verschaeve
Observed institutions: Cliniques Universitaires Saint-Luc, University of Arizona, Merck KGaA, Darmstadt (Germany), Universitair Ziekenhuis Leuven, Hospital de Sant Pau, Institut Jules Bordet, Institut Gustave Roussy, Shizuoka Cancer Center, Clinique Saint Pierre, Marqués de Valdecilla University Hospital, Antwerp University Hospital, Hôpital Européen Georges-Pompidou, Institut Català d'Oncologia, Hôpital de Jolimont, Centre Hospitalier Interrégional Edith Cavell, Hospital Universitario Virgen del Rocío, Centre Hospitalier Universitaire de Saint-Pierre, Institut Strauss, UCLouvain, KU Leuven
ORCID: 0000-0001-7968-1563
Observed ORCIDs: 0000-0001-7968-1563, 0000-0002-0575-6304
OpenAlex ID: A5027109717
Cancer and renal insufficiency results of the BIRMA study
2010 · N Janus, V Launay-vacher, et al. · British Journal of Cancer · 195
PDF
Phase I/II Study of Cetuximab in Combination With Cisplatin or Carboplatin and Fluorouracil in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
2006 · Jean Bourhis, Fernando Rivera, et al. · Journal of Clinical Oncology · 175
Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer
2007 · J-P. Machiels, C. Sempoux, et al. · Annals of Oncology · 147
Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study
2005 · J.-P. Machiels, L. Duck, et al. · Annals of Oncology · 128
PDF
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial
2017 · Marco Colleoni, Weixiu Luo, et al. · The Lancet Oncology · 122
Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer
2003 · Filomena Mazzeo, Martine Berlière, et al. · Gynecologic Oncology · 99
Prospective Randomized Study Comparing Docetaxel, Estramustine, and Prednisone With Docetaxel and Prednisone in Metastatic Hormone-Refractory Prostate Cancer
2008 · Jean-Pascal Machiels, Filomena Mazzeo, et al. · Journal of Clinical Oncology · 87
PDF
A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer
2016 · Giuseppe Curigliano, Gilles Romieu, et al. · Breast Cancer Research and Treatment · 45
Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial
2019 · Kathleen M Mullane, Vicki A Morrison, et al. · The Lancet Infectious Diseases · 39
Nonadherence to imatinib treatment in patients with gastrointestinal stromal tumors: the ADAGIO study.
2011 · Filomena Mazzeo, Lionel Duck, et al. · PubMed · 36
Primary combined squamous and small cell carcinoma of the larynx: report of two cases and discussion of treatment modalities
2006 · Annelore Barbeaux, Lionel Duck, et al. · European Archives of Oto-Rhino-Laryngology · 32
Ecteinascidin‐743: Evidence of Activity in Advanced, Pretreated Soft Tissue and Bone Sarcoma Patients
2006 · G. Huygh, Paul M. J. Clement, et al. · Sarcoma · 28
PDF
Prospective observational study of treatment pattern, effectiveness and safety of zoledronic acid therapy beyond 24 months in patients with multiple myeloma or bone metastases from solid tumors
2013 · T. Van den Wyngaert, M. Delforge, et al. · Supportive Care in Cancer · 25
Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial
2025 · Etienne Brain, Olivier Mir, et al. · The Lancet · 24
Acute cardiac failure after sunitinib
2008 · J.-P. Machiels, N. Bletard, et al. · Annals of Oncology · 17
Treatment of a Primary Pulmonary Angiosarcoma
2004 · Lionel Duck, Jean-François Baurain, et al. · CHEST Journal · 12
Effect of plasmapheresis and splenectomy on parameters involved in vascular rejection of discordant xenografts in the swine to baboon model.
1994 · T Besse, L Duck, et al. · PubMed · 11
Phase I study of sorafenib in combination with docetaxel and prednisone in chemo-naïve patients with metastatic castration-resistant prostate cancer
2012 · Feby Mardjuadi, Jacques Medioni, et al. · Cancer Chemotherapy and Pharmacology · 10
A phase II study of preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with locally advanced rectal adenocarcinoma
2004 · L. R. Duck, C. Sempoux, et al. · Journal of Clinical Oncology · 10
Central diabetes insipidus induced by temozolomide: A report of two cases
2020 · Cédric Mahiat, Antoine Capes, et al. · Journal of Oncology Pharmacy Practice · 8
Treatment of patients with newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC) in Belgium: a real world data analysis
2021 · E Lambert, S Hollebosch, et al. · Acta Clinica Belgica · 7
260 A phase II study of preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with locally advanced rectal adenocarcinoma: the RadiOxCape study
2003 · B. Honhon, L. Duck, et al. · European Journal of Cancer Supplements · 7
Evaluating pain management practices for cancer patients among health professionals in cancer and supportive/palliative care units: a Belgian survey
2024 · Christel Fontaine, Isabelle Libert, et al. · Supportive Care in Cancer · 5
PDF
Case report: Multidrug resistant gestational trophoblastic neoplasia: focus on failure of immunotherapy and success of high-dose chemotherapy
2024 · Anne Enuset, Lionel Duck, et al. · Frontiers in Oncology · 5
PDF
Immune checkpoint inhibitor refractory colitis leading to total colectomy in a melanoma patient
2023 · N Baczewska, M Philippart, et al. · Acta gastro-enterologica belgica · 5
PDF
Works count: 49
Citation count: 1,323
H-index: 15
I10-index: 19
Year
Topic
Type